Literature DB >> 2822768

Effects of catecholamines on secretion of adrenocorticotrophic hormone (ACTH) in man.

S Al-Damluji1, L H Rees.   

Abstract

The hypothalamus receives a rich supply of adrenergic and noradrenergic nerve fibres from the brain stem, terminating in many hypothalamic regions, including the paraventricular nucleus, which is the site of the cell bodies of corticotrophin releasing factor (CRF) neurones in man. Experimental evidence has shown that an alpha 1 adrenoceptor mechanism stimulates adrenocorticotrophic hormone (ACTH) secretion in man. The site of action of this mechanism seems to be within the blood brain barrier, presumably modulating the secretion of the CRF complex. This mechanism is important in the control of ACTH secretion in some physiological conditions in healthy subjects.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2822768      PMCID： PMC1141177          DOI： 10.1136/jcp.40.9.1098

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  102 in total

1.  Regional distribution of adrenaline in rat brain.

Authors:  J Van der Gugten; M Palkovits; H L Wijnen; D H Versteeg
Journal:  Brain Res       Date:  1976-04-30       Impact factor: 3.252

2.  The effect of alpha adrenergic manipulation on the 24 hour pattern of cortisol secretion in man.

Authors:  S Al-Damluji; D Cunnah; L Perry; A Grossman; G M Besser
Journal:  Clin Endocrinol (Oxf)       Date:  1987-01       Impact factor: 3.478

3.  Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB 154). A preliminary report.

Authors:  E Del Pozo; H Friesen; P Burmeister
Journal:  Schweiz Med Wochenschr       Date:  1973-06-09

4.  Adrenergic blockade and the corticosteroid and growth hormone responses to methylamphetamine.

Authors:  L Rees; P W Butler; C Gosling; G M Besser
Journal:  Nature       Date:  1970-11-07       Impact factor: 49.962

5.  Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus.

Authors:  F E Bloom; E L Battenberg; J Rivier; W Vale
Journal:  Regul Pept       Date:  1982-06

6.  The effect of peripheral catecholamine concentrations on the pituitary-adrenal response to corticotrophin releasing factor in man.

Authors:  S R Milsom; R A Donald; E A Espiner; M G Nicholls; J H Livesey
Journal:  Clin Endocrinol (Oxf)       Date:  1986-09       Impact factor: 3.478

7.  Monoamines in the pituitary gland of the pig.

Authors:  A Björklund; B Falck; E Rosengren
Journal:  Life Sci       Date:  1967-10-01       Impact factor: 5.037

8.  Dopamine effects on adrenocorticotrophin-stimulated aldosterone, cortisol, corticosterone and 11-deoxycorticosteroid concentrations in sodium-replete and sodium-deplete man.

Authors:  J M Connell; C J Kenyon; S G Ball; D L Davies; R Fraser
Journal:  J Endocrinol       Date:  1986-06       Impact factor: 4.286

9.  Characterization of beta-adrenergic receptors in rat brain and pituitary using a new high-affinity ligand, [125I]iodocyanopindolol.

Authors:  S L Petrovic; J K McDonald; G D Snyder; S M McCann
Journal:  Brain Res       Date:  1983-02-21       Impact factor: 3.252

10.  Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.

Authors:  W E Clutter; D M Bier; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808
View more
  6 in total

Review 1.  Measuring the activity of brain adrenergic receptors in man.

Authors:  S al-Damluji
Journal:  J Endocrinol Invest       Date:  1991-03       Impact factor: 4.256

2.  Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors.

Authors:  P Hartikainen; H Soininen; K J Reinikainen; J Sirviö; R Soikkeli; P J Riekkinen
Journal:  J Neural Transm Gen Sect       Date:  1991

3.  Ectopic ACTH-producing neuroendocrine tumor occurring with large recurrent metastatic pheochromocytoma: a case report.

Authors:  Fumi Saishouji; Sarie Maeda; Hideaki Hamada; Noriko Kimura; Ai Tamanoi; Saiko Nishida; Masaji Sakaguchi; Motoyuki Igata; Kiho Yokoo; Fumi Kawakami; Eiichi Araki; Tatsuya Kondo
Journal:  BMC Endocr Disord       Date:  2022-07-19       Impact factor: 3.263

4.  Validity of urinary monoamine assay sales under the "spot baseline urinary neurotransmitter testing marketing model".

Authors:  Marty Hinz; Alvin Stein; Thomas Uncini
Journal:  Int J Nephrol Renovasc Dis       Date:  2011-07-20

Review 5.  Particulate matter air pollutants and cardiovascular disease: Strategies for intervention.

Authors:  Ankit Aryal; Ashlyn C Harmon; Tammy R Dugas
Journal:  Pharmacol Ther       Date:  2021-05-14       Impact factor: 13.400

6.  The Parkinson's disease death rate: carbidopa and vitamin B6.

Authors:  Marty Hinz; Alvin Stein; Ted Cole
Journal:  Clin Pharmacol       Date:  2014-10-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.